Contract Consulting & Pharmaceutical Services - Part 1

Publication
Article
BioPharm InternationalBioPharm International-09-02-2009
Volume 2009 Supplement
Issue 5

To assess current trends in outsourcing, BioPharm International turned to Mark Douglas, PhD, strategic business development manager, Avecia Biologics Ltd; Geoffrey M. Glass, senior vice president of strategy, corporate development and business integration, Patheon Inc.; Rob Gustines, director of marketing, KBI Biopharma, Inc.; Jon S. Kauffman, PhD, director, method development & method validation and biopharmaceutical services, Lancaster Laboratories; Roger Lias, PhD, president, Eden Biodesign, Inc.; John A. McCarty, vice president, formulation sciences and drug delivery, Azopharma; and Michiel E. Ultee, PhD, vice president, process sciences, Laureate Pharma, Inc.

Articles in this issue
Contract Consulting & Pharmaceutical Services - Part 1
Contract Consulting & Pharmaceutical Services - Part 2
Contract Consulting & Pharmaceutical Services - Part 3
Downstream Processing
Contract Consulting & Pharmaceutical Services - Part 1
Single-Use Bioprocessing Equipment
Laboratory Equipment
Information Technology, Automation, and Process Control
Fermentation and Cell Culture
BioPharm International, September 2009 Industry Directory Supplement (PDF)
Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Exogenus Therapeutics Partners with Lonza on Manufacture of Exosome-Based Candidate

Susan Haigney
March 13th 2025
Article

Lonza will develop a GMP-compliant process for Exogenus’ exosome-based lead candidate, Exo-101, at its Sienna, Italy site.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.

International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma

Felicity Thomas
March 8th 2025
Article

In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Symbiosis Reports Successful Completion of FDA Inspection of Scotland Facilities

Patrick Lavery
March 6th 2025
Article

The inspection focused on fill/finish of ongoing commercial supplies of an adeno-associated virus viral vector biologics product for a major pharmaceutical client in the United States.

Hand holding light bulb against nature on green leaves with icons energy sources for renewable, sustainable development. Ecology concept. | Image Credit: © ipopba – stock.adobe.com

Supplying Sustainably

Susan Haigney
February 26th 2025
Article

Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce ‘green’ products.

Circular economy concept. Energy consumption and CO2 emissions are increasing. Sharing,reusing,repairing,renovating and recycling existing materials and products as much possible. | Image Credit: ©Miha Creative- stock.adobe.com

Working Together to Improve the Environment

Susan Haigney
February 26th 2025
Article

Contractors are working with sponsor companies to establish and maintain sustainable manufacturing practices in pharma.

© 2025 MJH Life Sciences

All rights reserved.